Role of wall teichoic acids in Staphylococcus aureus endophthalmitis

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 6, 2011, Pages 3187-3192

  Suzuki, Takashi ^a   Campbell, Jennifer ^a   Swoboda, Jonathan G ^a   Walker, Suzanne ^a   Gilmore, Michael S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; TARGOCIL; TEICHOIC ACID; TUNICAMYCIN; UNCLASSIFIED DRUG; TEICOPLANIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; CELL STRUCTURE; CONTROLLED STUDY; DRUG EFFICACY; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; VITREOUS BODY; ANIMAL; BACTERIAL COUNT; BACTERIAL EYE INFECTION; C57BL MOUSE; CATTLE; CELL WALL; DRUG ANTAGONISM; DRUG EFFECT; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; STAPHYLOCOCCUS INFECTION; VIRULENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CELL WALL; COLONY COUNT, MICROBIAL; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; MICE; MICE, INBRED C57BL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS; TEICOPLANIN; TUNICAMYCIN; VIRULENCE; VITREOUS BODY;

EID: 79960942202     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6558     Document Type: Article

References (40)

1. Callegan MC, Engelbert M, Parke DW 2nd, Jett BD, Gilmore MS. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15:111-124.
2. West ES, Behrens A, McDonnell PJ, Tielsch JM, Schein OD. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology. 2005;112:1388-1394.
3. Speaker MG, Milch FA, Shah MK, Eisner W, Kreiswirth BN. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 98:639-649, 1991; discussion 650.
4. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J Antimicrob Chemother. 2009;64:441-446.
5. Rutar T, Chambers HF, Crawford JB et al. Ophthalmic manifestations of infections caused by the USA300 clone of communityassociated methicillin-resistant Staphylococcus aureus. Ophthalmology. 2006;113:1455-1462.
6. Deramo VA, Lai JC, Winokur J, Luchs J, Udell IJ. Visual outcome and bacterial sensitivity after methicillin-resistant Staphylococcus aureus-associated acute endophthalmitis. Am J Ophthalmol. 2008; 145:413-417.
7. Major JC Jr, Engelbert M, Flynn HW Jr, Miller D, Smiddy WE, Davis JL. Staphylococcus aureus endophthalmitis: antibiotic susceptibilities, methicillin resistance, and clinical outcomes. Am J Ophthalmol. 2010;149:278-283.
8. Chang S, Sievert DM, Hageman JC, et al. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med. 2003;348:1342-1347.
9. Peterson DL. Vancomycin-resistant Staphylococcus aureus. Infect Med. 1999;16:235-238.
10. Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC. Vancomycin-resistant Staphylococcus aureus in the United States. 2002-2006. Clin Infect Dis. 2008;46:668-674.
11. Swoboda JG, Campbell J, Meredith TC, Walker S. Wall teichoic acid function, biosynthesis, and inhibition. Chembiochem. 2010: 11:35-45.
12. Weidenmaier C, Kokai-Kun JF, Kristian SA, et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections. Nat Med. 2004;10:243-245.
13. Weidenmaier C, Kokai-Kun JF, Kulauzovic E, et al. Differential roles of sortase-anchored surface proteins and wall teichoic acid in Staphylococcus aureus nasal colonization. Int J Med Microbiol. 2008;298:505-513.
14. Weidenmaier C, Peschel A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat Rev Microbiol. 2008;6:276-287.
15. Weidenmaier C, Peschel A, Xiong YQ, et al. Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis. J Infect Dis. 2005;191:1771-1777.
16. D'Elia MA, Pereira MP, Chung YS, et al. Lesions in teichoic acid biosynthesis in Staphylococcus aureus lead to a lethal gain of function in the otherwise dispensable pathway. J Bacteriol. 2006; 188:4183-4189.
17. Swoboda JG, Meredith TC, Campbell J, et al. Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus. ACS Chem Biol. 2009;4:875-883.
18. Lee K, Campbell J, Swoboda JG, Cuny GD, Walker S. Development of improved inhibitors of wall teichoic acid biosynthesis with potent activity against Staphylococcus aureus. Bioorg Med Chem Lett. 20:1767-1770.
19. Peng HL, Novick RP, Kreiswirth B, Kornblum J, Schlievert P. Cloning, characterization, and sequencing of an accessory gene regulator (agr) in Staphylococcus aureus. J Bacteriol. 1988;170: 4365-4372.
20. Kreiswirth BN, Lofdahl S, Betley MJ, et al. The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophage. Nature. 1983;305:709-712.
21. Grundling A, Schneewind O. Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus. J Bacteriol. 2006;188:2463-2472.
22. Bae T, Schneewind O. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid. 2006;55:58-63.
23. Meredith TC, Swoboda JG, Walker S. Late-stage polyribitol phosphate wall teichoic acid biosynthesis in Staphylococcus aureus. J Bacteriol. 2008;190:3046-3056.
24. Price NP, Tsvetanova B. Biosynthesis of the tunicamycins: a review. J Antibiot (Tokyo). 2007;60:485-491.
25. Gipson IK, Grill SM, Spurr SJ, Brennan SJ. Hemidesmosome formation in vitro. J Cell Biol. 1983;97:849-857.
26. Engelbert M, Gilmore MS. Fas ligand but not complement is critical for control of experimental Staphylococcus aureus Endophthalmitis. Invest Ophthalmol Vis Sci. 2005;46:2479-2486.
27. Whiston EA, Sugi N, Kamradt MC, et al. alphaB-crystallin protects retinal tissue during Staphylococcus aureus-induced endophthalmitis. Infect Immun. 2008;76:1781-1790.
28. Koprivnjak T, Weidenmaier C, Peschel A, Weiss JP. Wall teichoic acid deficiency in Staphylococcus aureus confers selective resistance to mammalian group IIA phospholipase A(2) and human beta-defensin 3. Infect Immun. 2008;76:2169-2176.
29. D'Elia MA, Millar KE, Beveridge TJ, Brown ED. Wall teichoic acid polymers are dispensable for cell viability in Bacillus subtilis. J Bacteriol. 2006;188:8313-8316.
30. Hubscher J, McCallum N, Sifri CD, et al. MsrR contributes to cell surface characteristics and virulence in Staphylococcus aureus. FEMS Microbiol Lett. 2009;295:251-260.
31. Pereira SF, Henriques AO, Pinho MG, de Lencastre H, Tomasz A. Role of PBP1 in cell division of Staphylococcus aureus. J Bacteriol. 2007;189:3525-3531.
32. Coutselinis A, Boukis D, Kalofoutis A. Concentrations of some trace elements in vitreous humor after death. Clin Chem. 1977; 23:915-916.
33. Davey P, Barza M, Peckman C. Spontaneous inhibition of bacterial growth in experimental gram-negative endophthalmitis. Invest Ophthalmol Vis Sci. 1987;28:867-873.
34. Haynes RJ, McElveen JE, Dua HS, Tighe PJ, Liversidge J. Expression of human beta-defensins in intraocular tissues. Invest Ophthalmol Vis Sci. 2000;41:3026-3031.
35. Yamagata M, Rook SL, Sassa Y, et al. Bactericidal/permeabilityincreasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects. FASEB J. 2006;20:2058-2067.
36. Stainer GA, Peyman GA, Berkowitz R, Tessler HH. Intraocular lysozyme in experimental uveitis in rabbits: aqueous and vitreous assay. Invest Ophthalmol. 1976;15:312-315.
37. Bera A, Biswas R, Herbert S, et al. Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J Bacteriol. 2007; 189:280-283.
38. Houghton AM, Hartzell WO, Robbins CS, Gomis-Ruth FX, Shapiro SD. Macrophage elastase kills bacteria within murine macrophages. Nature. 2009;460:637-641.
39. Standish AJ, Weiser JN. Human neutrophils kill Streptococcus pneumoniae via serine proteases. J Immunol. 2009;183:2602-2609.
40. Belaaouaj A, Kim KS, Shapiro SD. Degradation of outer membrane protein A in Escherichia coli killing by neutrophil elastase. Science. 2000;289:1185-1188.